FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

C. Corno, S. Stucchi, M. De Cesare, N. Carenini, S. Stamatakos, E. Ciusani, L. Minoli, E. Scanziani, C. Argueta, Y. Landesman, N. Zaffaroni, L. Gatti, P. Perego

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)93-103
Number of pages11
JournalBiochemical Pharmacology
Volume147
DOIs
Publication statusPublished - 2018

Cite this

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models. / Corno, C.; Stucchi, S.; De Cesare, M.; Carenini, N.; Stamatakos, S.; Ciusani, E.; Minoli, L.; Scanziani, E.; Argueta, C.; Landesman, Y.; Zaffaroni, N.; Gatti, L.; Perego, P.

In: Biochemical Pharmacology, Vol. 147, 2018, p. 93-103.

Research output: Contribution to journalArticle

@article{f65ff80dc23e4656aead64bf9df5188e,
title = "FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models",
author = "C. Corno and S. Stucchi and {De Cesare}, M. and N. Carenini and S. Stamatakos and E. Ciusani and L. Minoli and E. Scanziani and C. Argueta and Y. Landesman and N. Zaffaroni and L. Gatti and P. Perego",
note = "cited By 0",
year = "2018",
doi = "10.1016/j.bcp.2017.11.009",
language = "Non definita",
volume = "147",
pages = "93--103",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

AU - Corno, C.

AU - Stucchi, S.

AU - De Cesare, M.

AU - Carenini, N.

AU - Stamatakos, S.

AU - Ciusani, E.

AU - Minoli, L.

AU - Scanziani, E.

AU - Argueta, C.

AU - Landesman, Y.

AU - Zaffaroni, N.

AU - Gatti, L.

AU - Perego, P.

N1 - cited By 0

PY - 2018

Y1 - 2018

U2 - 10.1016/j.bcp.2017.11.009

DO - 10.1016/j.bcp.2017.11.009

M3 - Articolo

VL - 147

SP - 93

EP - 103

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

ER -